Cabaletta Bio Debt To Equity vs. Cash And Equivalents

CABA Stock  USD 3.51  0.05  1.40%   
Considering Cabaletta Bio's profitability and operating efficiency indicators, Cabaletta Bio may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in January. Profitability indicators assess Cabaletta Bio's ability to earn profits and add value for shareholders.
 
Debt To Equity  
First Reported
2010-12-31
Previous Quarter
0.0150721
Current Value
0.0198
Quarterly Volatility
0.00149645
 
Credit Downgrade
 
Yuan Drop
 
Covid
At present, Cabaletta Bio's PTB Ratio is projected to increase significantly based on the last few years of reporting. The current year's Book Value Per Share is expected to grow to 6.06, whereas Free Cash Flow Yield is forecasted to decline to (0.06).
For Cabaletta Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Cabaletta Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Cabaletta Bio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Cabaletta Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Cabaletta Bio over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cabaletta Bio. If investors know Cabaletta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cabaletta Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.13)
Return On Assets
(0.31)
Return On Equity
(0.48)
The market value of Cabaletta Bio is measured differently than its book value, which is the value of Cabaletta that is recorded on the company's balance sheet. Investors also form their own opinion of Cabaletta Bio's value that differs from its market value or its book value, called intrinsic value, which is Cabaletta Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cabaletta Bio's market value can be influenced by many factors that don't directly affect Cabaletta Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cabaletta Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cabaletta Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cabaletta Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Cabaletta Bio Cash And Equivalents vs. Debt To Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Cabaletta Bio's current stock value. Our valuation model uses many indicators to compare Cabaletta Bio value to that of its competitors to determine the firm's financial worth.
Cabaletta Bio is rated below average in debt to equity category among its peers. It is rated below average in cash and equivalents category among its peers . At present, Cabaletta Bio's Debt To Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cabaletta Bio's earnings, one of the primary drivers of an investment's value.

Cabaletta Cash And Equivalents vs. Debt To Equity

Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

Cabaletta Bio

D/E

 = 

Total Debt

Total Equity

 = 
(3.76) %
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Cabaletta Bio

Cash

 = 

Bank Deposits

+

Liquidities

 = 
96.81 M
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).

Cabaletta Cash And Equivalents Comparison

Cabaletta Bio is currently under evaluation in cash and equivalents category among its peers.

Cabaletta Bio Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Cabaletta Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Cabaletta Bio will eventually generate negative long term returns. The profitability progress is the general direction of Cabaletta Bio's change in net profit over the period of time. It can combine multiple indicators of Cabaletta Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income39 K41 K
Operating Income-74.7 M-70.9 M
Net Loss-67.7 M-64.3 M
Income Before Tax-67.7 M-64.3 M
Net Loss-47.7 M-45.3 M
Net Loss-67.7 M-64.3 M
Net Interest IncomeM7.3 M
Interest IncomeM7.3 M
Total Other Income Expense NetM7.3 M
Income Tax Expense-1 M-1.1 M
Non Operating Income Net Other1.3 M911.9 K
Change To Netincome6.2 M4.7 M
Net Loss(1.65)(1.74)
Income Quality 0.79  0.61 
Net Income Per E B T 0.88  0.77 

Cabaletta Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Cabaletta Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Cabaletta Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Cabaletta Bio's important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in Cabaletta Bio without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Odds Of Bankruptcy Now

   

Odds Of Bankruptcy

Get analysis of equity chance of financial distress in the next 2 years
All  Next Launch Module

Use Investing Themes to Complement your Cabaletta Bio position

In addition to having Cabaletta Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Utilities Thematic Idea Now

Utilities
Utilities Theme
Highly leveraged corporations that deliver utilities such as power, water or gas to public or business. The Utilities theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Utilities Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Cabaletta Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cabaletta Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cabaletta Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cabaletta Bio Stock:
Check out Trending Equities.
For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
To fully project Cabaletta Bio's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Cabaletta Bio at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Cabaletta Bio's income statement, its balance sheet, and the statement of cash flows.
Potential Cabaletta Bio investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Cabaletta Bio investors may work on each financial statement separately, they are all related. The changes in Cabaletta Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Cabaletta Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.